gain more customers in both the private and also the corporate banking sector but that is just one side of the story i would say commerce one is set to open their books on may fifteenth analysts fear that another loss of profits will be announced and they also want to share price to go up again during the last three months it s lost almost fifteen percent all right daniel there s another story that i d like to discuss with you in just a short while don t go away because one of the biggest takeovers in the history of the pharmaceutical industry is about to roll out after months of negotiations taking over irish rival shire will make the ninth biggest pharmaceutical company in the world the deal is valued at sixty two billion u.s. dollars the most a japanese company has ever spent on overseas acquisition to get it is hoping to gain better access to the global market but some analysts are skeptical about the breathtaking amounts instigator is currently valued at just thirty three billion
similar commitments before with little implementation this time around however the stakes are higher insufficient action could pave the way for further escalation. looks like the last major hurdle is gone reports the u.s. has cleared the mega merger between buyer and monsanto the share prices skyrocketing today farmers fear the same for seed prices a deal would hand the companies a monopoly that s why officials have insisted by divest additional assets the german drugs and pesticides group intending to buy the american agricultural colossus for of a sixty two billion dollars if all goes smoothly this will be the biggest ever takeover of a u.s. company by a german one. public sector warning strikes have hit germany expect travel delays lufthansa has canceled hundreds of flights industrial action is also affecting nurseries and rubbish collection as the german economy expands the workers want to
was not mentioned they feel that this could also mean less possibility off a trade war between china and the u.s. a big plus by the way also this morning for the german carmaker volkswagen the market in china for them extremely important and we ve heard of they re also thinking about having lower tariffs on car imports from other countries as well all right thanks to you stay with us because we will be coming back to you in just a moment but first according to reports the u.s. justice department will give the green light to german pharma giant buyers take over all of monsanto that just a few weeks off the potential deal was given the ok by the e.u. commission by tends to buy the u.s. agricultural colossus for sixty two billion dollars u.s. officials have insisted that by divest additional assets as part of the deal before now goes smoothly the mega deal will be the biggest ever take over all of a u.s. company by a german one. back over to daniel in frankfurt daniel so this merger appea
a sixty two billion euro tile with agriculture call for monsanto weren t enough twenty seventeen s consumer drug sales were stagnant. system and consumer. we re not satisfied with the development of consumer health. on the one hand competitive forces in the usa require extra investment in our brands. and then in twenty seven teens the unusual situation in china where several over the counter drugs became prescription only product which you could do. and. by as problems are stacking up it s now willing to sell more parts of its business that s to convince authorities to wade through the purchase of monsanto the u.s. food and drug administration is threatening to take buy our products off the shelves of a quality control issues and breck s it could force pharma firms to do the splits
of aspirin has some headaches of its own germany is renowned for masuda called giant buyer disappoints investors with weak figures for last year we ll take a closer look. also coming up education alone is not enough tens of thousands of young people in eastern europe are forced to leave their homes to earn a living elsewhere. and some for business on the w m how you know i guess welcome to the program buyer is under pressure to perform sherm shares in the german life sciences company tumbled more than three percent after it announced disappointing financial results for twenty seventeen buyer faces challenges on multiple fronts and some of them are out of its control. if by investors were hoping for good news on wednesday they didn t get much as if multiple delays in the approval of a sixty two billion euro tie up with our chemical for monsanto weren t enough twenty seven teams consumer drug sales were stagnant. system and consumer.